These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19644645)

  • 21. Results of long-term vasodilator therapy in patients with refractory congestive heart failure.
    Walsh WF; Greenberg BH
    Circulation; 1981 Sep; 64(3):499-505. PubMed ID: 7261282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of using vasodilating preparations in latent heart failure in patients with chronic ischemic heart disease].
    Volkov VS; Bratoliubov VP
    Kardiologiia; 1984 Aug; 24(8):89-92. PubMed ID: 6436573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Afterload reduction in the management of congestive heart failure following acute myocardial infarction.
    Miller RR; Awan NA; Mason DT
    Adv Cardiol; 1978; 23():173-81. PubMed ID: 345758
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance.
    Starling MR
    Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemodynamic effects of hydralazine in the cardiac insufficiency of non-obstructive myocardiopathy].
    Pailloncy M; Fernandez F; Lelguen C; Datchary J; Ponsonnaille J; Gerbaux A; Gras H
    Arch Mal Coeur Vaiss; 1979 Mar; 72(3):276-83. PubMed ID: 114138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC; Robinson PH
    Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.
    Massie B; Ports T; Chatterjee K; Parmley W; Ostland J; O'Young J; Haughom F
    Circulation; 1981 Feb; 63(2):269-78. PubMed ID: 6778625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative evaluation of the effectiveness of using peripheral vasodilators in the treatment of patients with acute myocardial infarction complicated by left-ventricular failure].
    Uchaĭkina LV; Zolotareva NIu; Vakhliaev VD; Smirnova IE
    Kardiologiia; 1991 Dec; 31(12):15-8. PubMed ID: 1816434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical pearls in cardiology.
    Kopecky SL; Litin SC
    Mayo Clin Proc; 2010 May; 85(5):473-8. PubMed ID: 20435840
    [No Abstract]   [Full Text] [Related]  

  • 32. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assessment of daily physical activity levels in patients with chronic heart failure by measuring energy expenditure--effects of converting enzyme inhibitor therapy.
    Sato H; Hori M; Ozaki H; Yokoyama H; Imai K; Katsube Y; Morikawa M; Inoue M; Kamada T
    Jpn Circ J; 1995 Oct; 59(10):647-53. PubMed ID: 8558748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of vasodilator therapy in severe left heart failure combined with large atrial septal defects.
    Kolibash AJ; Magorien RD; Robinson JL; Leier CV
    Am J Med; 1982 Sep; 73(3):439-4. PubMed ID: 7124771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
    Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
    Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic treatment with vasodilators of heart failure. I. Hydralazine treatment].
    Dumitriu M; Costică II; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(4):349-63. PubMed ID: 6150539
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of infarct related heart failure: vasodilators other than ACE inhibitors.
    Cohn JN
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):119-22. PubMed ID: 8086321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
    Juillière Y; Feldmann L; Perrin O; Berder V; Danchin N; Cherrier F
    Int J Cardiol; 1995 Nov; 52(1):17-22. PubMed ID: 8707430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Options of NO substitution: proven and future methods. A pharmaceutical classic on the upswing].
    MMW Fortschr Med; 2011 Jun; 153(24-25):50-1. PubMed ID: 21717713
    [No Abstract]   [Full Text] [Related]  

  • 40. Serelaxin for infant heart failure in congenital dilated cardiomyopathy.
    Myers PO; Bordessoule A; Tissot C
    Cardiol Young; 2018 May; 28(5):734-736. PubMed ID: 29332614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.